share_log

海思科(002653.SZ)：HSK16149胶囊临床试验获批

HiCisco (002653.SZ): HSK16149 capsule clinical trial approved

Zhitong Finance ·  Apr 17 16:35

HiCisco (002653.SZ) issued an announcement. The company recently received “Drugs...” issued by the State Drug Administration

Zhitong Finance App News, HiCisco (002653.SZ) issued an announcement. The company recently received the “Drug Clinical Trial Approval Notice” issued by the State Drug Administration. After review, the HSK16149 capsule clinical trial application accepted in January 2024 met the relevant requirements for drug registration and agreed to carry out clinical trials with the sample.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment